Back to search

Gene therapy through signal transduction pathways and angiogenic growth factors as therapeutic targets in breast cancer

Data up to Jan 2025

Published1994
Citations38
References49

Total Citations Per Year

Abstract

References (49)

Human Breast Cancer: Correlation of Relapse and Survival with Amplification of the HER-2/ neu Oncogene

1987 • 11,429 citations

Tumor Angiogenesis and Metastasis — Correlation in Invasive Breast Carcinoma

1991 • 5,657 citations

Oncogenes and signal transduction

1991 • 2,816 citations

Tumor Angiogenesis: A New Significant and Independent Prognostic Indicator in Early-Stage Breast Carcinoma

1992 • 1,799 citations

Molecular and Biological Properties of the Vascular Endothelial Growth Factor Family of Proteins

1992 • 1,612 citations

EPIDERMAL-GROWTH-FACTOR RECEPTOR STATUS AS PREDICTOR OF EARLY RECURRENCE OF AND DEATH FROM BREAST CANCER

1987 • 881 citations

Angiogenesis, assessed by platelet/endothelial cell adhesion molecule antibodies, as indicator of node metastases and survival in breast cancer

1992 • 822 citations

Ligand-specific activation of HER4/p180erbB4, a fourth member of the epidermal growth factor receptor family.

1993 • 724 citations

Sequences encoded in the class II region of the MHC related to the 'ABC' superfamily of transporters

1990 • 717 citations

Isolation and structure of bryostatin 1

1982 • 638 citations

Expression of c-erbB-2 oncoprotein: a prognostic indicator in human breast cancer.

1989 • 592 citations

A dual receptor system is required for basic fibroblast growth factor activity

1991 • 589 citations

Microvessel quantitation and prognosis in invasive breast carcinoma

1992 • 566 citations

Release of basic fibroblast growth factor-heparan sulfate complexes from endothelial cells by plasminogen activator-mediated proteolytic activity.

1990 • 545 citations

Transforming growth factor beta 1-induced changes in cell migration, proliferation, and angiogenesis in the chicken chorioallantoic membrane.

1990 • 470 citations

JC70: a new monoclonal antibody that detects vascular endothelium associated antigen on routinely processed tissue sections.

1990 • 428 citations

Fibroblast growth factors are present in the extracellular matrix produced by endothelial cells invitro: Implications for a role of heparinase-like enzymes in the neovascular response

1987 • 416 citations

Assembly and function of the two ABC transporter proteins encoded in the human major histocompatibility complex

1992 • 407 citations

Karnofsky Memorial Lecture. The immunotherapy and gene therapy of cancer.

1992 • 394 citations

Suramin: an anticancer drug with a unique mechanism of action.

1989 • 370 citations

Induction of neovascularization in vivo and endothelial proliferation in vitro by tumor-associated macrophages.

1984 • 366 citations

Peptide binding to class I MHC on living cells and quantitation of complexes required for CTL lysis

1991 • 336 citations

EXPRESSION OF EPIDERMAL GROWTH FACTOR RECEPTORS ASSOCIATED WITH LACK OF RESPONSE TO ENDOCRINE THERAPY IN RECURRENT BREAST CANCER

1989 • 224 citations

In vitro and in vivo targeting of gene expression to melanoma cells.

1993 • 190 citations

Epidermal growth factor receptor (EGFr); results of a 6 year follow-up study in operable breast cancer with emphasis on the node negative subgroup

1991 • 171 citations

Novel growth regulatory factors and tumour angiogenesis

1991 • 162 citations

Quantitative in-vivo studies on angiogenesis in a rat sponge model.

1987 • 143 citations

The mitogenic signaling pathway but not the plasminogen activator-inducing pathway of basic fibroblast growth factor is mediated through protein kinase C in fetal bovine aortic endothelial cells.

1989 • 133 citations

Vascular endothelial cell growth factor (VEGF) produced by A-431 human epidermoid carcinoma cells and identification of VEGF membrane binding sites.

1991 • 115 citations

Vasculature as a Target for Tumour Therapy

2015 • 109 citations

Tumor Growth Dependent on Kaposi's Sarcoma-Derived Fibroblast Growth Factor Inhibited by Pentosan Polysulfate

1991 • 106 citations

Suramin: prototype of a new generation of antitumor compounds.

1990 • 101 citations

Epidermal growth factor receptor and other oncogenes as prognostic markers.

1992 • 98 citations

Correlation between hormone dependency and the regulation of epidermal growth factor receptor by tumor promoters in human mammary carcinoma cells.

1986 • 98 citations

Protein kinase C activators suppress stimulation of capillary endothelial cell growth by angiogenic endothelial mitogens.

1987 • 97 citations

Successful treatment of murine melanoma with bryostatin 1.

1991 • 94 citations

Heparin-binding growth factor 1 stimulates tyrosine phosphorylation in NIH 3T3 cells.

1989 • 85 citations

Monoclonal antibodies directed against basic fibroblast growth factor which inhibit its biological activity in vitro and in vivo

1989 • 72 citations

Anticancer strategies involving the vasculature: vascular targeting and the inhibition of angiogenesis.

1992 • 65 citations

Loss of HLA class‐I alleles, heavy chains and β2‐microglobulin in colorectal cancer

1992 • 61 citations

Gene expression and immunohistochemical localization of basic fibroblast growth factor in renal cell carcinoma

1992 • 52 citations

Bifunctional effects of transforming growth factor-β (TGF-β) on endothelial cell growth correlate with phenotypes of TGF-β binding sites

1990 • 51 citations

Angiogenic effects of macrophages isolated from ascitic fluid aspirated from women with advanced ovarian cancer

1992 • 48 citations

Localization of platelet-derived endothelial cell growth factor in human placenta and purification of an alternatively processed form.

1990 • 44 citations

Phorbol ester and bryostatin effects on growth and the expression of oestrogen responsive and TGF-β1 genes in breast tumour cells

1991 • 28 citations

Growth control of normal and malignant breast epithelium.

1990 • 26 citations

Mast cell-basophil system in tumor growth.

1989 • 7 citations

The Therapeutic Implications of the Molecular Biology of Breast Cancer

1991 • 6 citations

PROGNOSTIC-SIGNIFICANCE OF C-ERBB-2 ONCOPROTEIN EXPRESSION IN BREAST-CANCER - AN IMMUNOHISTOCHEMICAL STUDY

1988 • 1 citations

Cited By (0)

No citing papers found in database

Gene therapy through signal transduction pathways and angiogenic growth factors as… (1994) – Cancer | Metascience Observatory Explorer